Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Critical Reviews in Oncology/Hematology|August 17, 2010
The chemokine network, a newly discovered target in high grade gliomasU M Domanska, R C Kruizinga, W F A den Dunnen, et al.
British Journal of Cancer|April 1, 1995
Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell linesM W Sark, H Timmer-Bosscha, C Meijer, et al.
Breast Cancer Research and Treatment|September 28, 2005
Timely withdrawal of G-CSF reduces the occurrence of thrombocytopenia during dose-dense chemotherapyJ N H Timmer-Bonte, P H M de Mulder, P G M Peer, et al.
British Journal of Cancer|May 3, 2002
Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1B A P van Gorkom, H Timmer-Bosscha, S de Jong, et al.
Journal of the National Cancer Institute|July 19, 1989
Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell lineH Timmer-Bosscha, G A Hospers, C Meijer, et al.
Water Research|October 13, 2009
Concentration and size distribution of particles in abstracted groundwaterC G E M van Beek, A H de Zwart, M Balemans, et al.
Human Reproduction (Oxford, England)|April 9, 2004
An in vitro model for purging of tumour cells from ovarian tissueC P Schröder, H Timmer-Bosscha, J G Wijchman, et al.
British Journal of Cancer|January 1, 1997
A new in vitro assay for quantitation of chemotherapy-induced mucositisA N Wymenga, W T van der Graaf, F L Spijkervet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2017
The Predictive Value of Early In-Treatment 18F-FDG PET/CT Response to Chemotherapy in Combination with Bevacizumab in Advanced Nonsquamous Non-Small Cell Lung CancerEdwin A Usmanij, Tinatin Natroshvili, Johanna N H Timmer-Bonte, et al.
British Journal of Cancer|September 30, 2010
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumoursC M L van Herpen, F A L M Eskens, M de Jonge, et al.
Pageof 8